Medical Care

Global Molecular Oncology Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Molecular Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Oncology.
The Molecular Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Diagnostics
Thermo Fisher Scientific Inc.
Illumina, Inc.
Qiagen N.V.
Agilent Technologies, Inc.
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Myriad Genetics, Inc.
Genomic Health, Inc.
Segment by Type
PCR
NGS (Next Generation Sequencing)
Microarray
FISH (Fluorescent in situ-hybridization)
Others
Segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Cancer Centers and Specialty Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 NGS (Next Generation Sequencing)
1.2.4 Microarray
1.2.5 FISH (Fluorescent in situ-hybridization)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Molecular Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Centers and Specialty Clinics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Oncology Market Perspective (2020-2031)
2.2 Global Molecular Oncology Growth Trends by Region
2.2.1 Global Molecular Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Oncology Historic Market Size by Region (2020-2025)
2.2.3 Molecular Oncology Forecasted Market Size by Region (2026-2031)
2.3 Molecular Oncology Market Dynamics
2.3.1 Molecular Oncology Industry Trends
2.3.2 Molecular Oncology Market Drivers
2.3.3 Molecular Oncology Market Challenges
2.3.4 Molecular Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Oncology Players by Revenue
3.1.1 Global Top Molecular Oncology Players by Revenue (2020-2025)
3.1.2 Global Molecular Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Top Molecular Oncology Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Oncology Revenue
3.4 Global Molecular Oncology Market Concentration Ratio
3.4.1 Global Molecular Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Oncology Revenue in 2024
3.5 Global Key Players of Molecular Oncology Head office and Area Served
3.6 Global Key Players of Molecular Oncology, Product and Application
3.7 Global Key Players of Molecular Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Oncology Breakdown Data by Type
4.1 Global Molecular Oncology Historic Market Size by Type (2020-2025)
4.2 Global Molecular Oncology Forecasted Market Size by Type (2026-2031)
5 Molecular Oncology Breakdown Data by Application
5.1 Global Molecular Oncology Historic Market Size by Application (2020-2025)
5.2 Global Molecular Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Oncology Market Size (2020-2031)
6.2 North America Molecular Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Oncology Market Size by Country (2020-2025)
6.4 North America Molecular Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Oncology Market Size (2020-2031)
7.2 Europe Molecular Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Oncology Market Size by Country (2020-2025)
7.4 Europe Molecular Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Oncology Market Size (2020-2031)
8.2 Asia-Pacific Molecular Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Oncology Market Size (2020-2031)
9.2 Latin America Molecular Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Oncology Market Size by Country (2020-2025)
9.4 Latin America Molecular Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Oncology Market Size (2020-2031)
10.2 Middle East & Africa Molecular Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Molecular Oncology Introduction
11.1.4 Roche Diagnostics Revenue in Molecular Oncology Business (2020-2025)
11.1.5 Roche Diagnostics Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Molecular Oncology Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (2020-2025)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Illumina, Inc.
11.3.1 Illumina, Inc. Company Details
11.3.2 Illumina, Inc. Business Overview
11.3.3 Illumina, Inc. Molecular Oncology Introduction
11.3.4 Illumina, Inc. Revenue in Molecular Oncology Business (2020-2025)
11.3.5 Illumina, Inc. Recent Development
11.4 Qiagen N.V.
11.4.1 Qiagen N.V. Company Details
11.4.2 Qiagen N.V. Business Overview
11.4.3 Qiagen N.V. Molecular Oncology Introduction
11.4.4 Qiagen N.V. Revenue in Molecular Oncology Business (2020-2025)
11.4.5 Qiagen N.V. Recent Development
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Details
11.5.2 Agilent Technologies, Inc. Business Overview
11.5.3 Agilent Technologies, Inc. Molecular Oncology Introduction
11.5.4 Agilent Technologies, Inc. Revenue in Molecular Oncology Business (2020-2025)
11.5.5 Agilent Technologies, Inc. Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Molecular Oncology Introduction
11.6.4 Abbott Laboratories Revenue in Molecular Oncology Business (2020-2025)
11.6.5 Abbott Laboratories Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Details
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Molecular Oncology Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (2020-2025)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Myriad Genetics, Inc.
11.8.1 Myriad Genetics, Inc. Company Details
11.8.2 Myriad Genetics, Inc. Business Overview
11.8.3 Myriad Genetics, Inc. Molecular Oncology Introduction
11.8.4 Myriad Genetics, Inc. Revenue in Molecular Oncology Business (2020-2025)
11.8.5 Myriad Genetics, Inc. Recent Development
11.9 Genomic Health, Inc.
11.9.1 Genomic Health, Inc. Company Details
11.9.2 Genomic Health, Inc. Business Overview
11.9.3 Genomic Health, Inc. Molecular Oncology Introduction
11.9.4 Genomic Health, Inc. Revenue in Molecular Oncology Business (2020-2025)
11.9.5 Genomic Health, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Molecular Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of NGS (Next Generation Sequencing)
Table 4. Key Players of Microarray
Table 5. Key Players of FISH (Fluorescent in situ-hybridization)
Table 6. Key Players of Others
Table 7. Global Molecular Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Molecular Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Molecular Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Molecular Oncology Market Share by Region (2020-2025)
Table 11. Global Molecular Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Molecular Oncology Market Share by Region (2026-2031)
Table 13. Molecular Oncology Market Trends
Table 14. Molecular Oncology Market Drivers
Table 15. Molecular Oncology Market Challenges
Table 16. Molecular Oncology Market Restraints
Table 17. Global Molecular Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Molecular Oncology Market Share by Players (2020-2025)
Table 19. Global Top Molecular Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Oncology as of 2024)
Table 20. Ranking of Global Top Molecular Oncology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Molecular Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Molecular Oncology, Headquarters and Area Served
Table 23. Global Key Players of Molecular Oncology, Product and Application
Table 24. Global Key Players of Molecular Oncology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Molecular Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Molecular Oncology Revenue Market Share by Type (2020-2025)
Table 28. Global Molecular Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Molecular Oncology Revenue Market Share by Type (2026-2031)
Table 30. Global Molecular Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Molecular Oncology Revenue Market Share by Application (2020-2025)
Table 32. Global Molecular Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Molecular Oncology Revenue Market Share by Application (2026-2031)
Table 34. North America Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Molecular Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Molecular Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Molecular Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Molecular Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Molecular Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Molecular Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Molecular Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Molecular Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Molecular Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Molecular Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Molecular Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Roche Diagnostics Company Details
Table 50. Roche Diagnostics Business Overview
Table 51. Roche Diagnostics Molecular Oncology Product
Table 52. Roche Diagnostics Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 53. Roche Diagnostics Recent Development
Table 54. Thermo Fisher Scientific Inc. Company Details
Table 55. Thermo Fisher Scientific Inc. Business Overview
Table 56. Thermo Fisher Scientific Inc. Molecular Oncology Product
Table 57. Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 58. Thermo Fisher Scientific Inc. Recent Development
Table 59. Illumina, Inc. Company Details
Table 60. Illumina, Inc. Business Overview
Table 61. Illumina, Inc. Molecular Oncology Product
Table 62. Illumina, Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 63. Illumina, Inc. Recent Development
Table 64. Qiagen N.V. Company Details
Table 65. Qiagen N.V. Business Overview
Table 66. Qiagen N.V. Molecular Oncology Product
Table 67. Qiagen N.V. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 68. Qiagen N.V. Recent Development
Table 69. Agilent Technologies, Inc. Company Details
Table 70. Agilent Technologies, Inc. Business Overview
Table 71. Agilent Technologies, Inc. Molecular Oncology Product
Table 72. Agilent Technologies, Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 73. Agilent Technologies, Inc. Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Molecular Oncology Product
Table 77. Abbott Laboratories Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Bio-Rad Laboratories, Inc. Company Details
Table 80. Bio-Rad Laboratories, Inc. Business Overview
Table 81. Bio-Rad Laboratories, Inc. Molecular Oncology Product
Table 82. Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 83. Bio-Rad Laboratories, Inc. Recent Development
Table 84. Myriad Genetics, Inc. Company Details
Table 85. Myriad Genetics, Inc. Business Overview
Table 86. Myriad Genetics, Inc. Molecular Oncology Product
Table 87. Myriad Genetics, Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 88. Myriad Genetics, Inc. Recent Development
Table 89. Genomic Health, Inc. Company Details
Table 90. Genomic Health, Inc. Business Overview
Table 91. Genomic Health, Inc. Molecular Oncology Product
Table 92. Genomic Health, Inc. Revenue in Molecular Oncology Business (2020-2025) & (US$ Million)
Table 93. Genomic Health, Inc. Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report


List of Figures
Figure 1. Molecular Oncology Picture
Figure 2. Global Molecular Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Oncology Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. NGS (Next Generation Sequencing) Features
Figure 6. Microarray Features
Figure 7. FISH (Fluorescent in situ-hybridization) Features
Figure 8. Others Features
Figure 9. Global Molecular Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Molecular Oncology Market Share by Application: 2024 VS 2031
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Cancer Centers and Specialty Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Molecular Oncology Report Years Considered
Figure 16. Global Molecular Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Molecular Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Molecular Oncology Market Share by Region: 2024 VS 2031
Figure 19. Global Molecular Oncology Market Share by Players in 2024
Figure 20. Global Molecular Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Molecular Oncology Revenue in 2024
Figure 22. North America Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Molecular Oncology Market Share by Country (2020-2031)
Figure 24. United States Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Molecular Oncology Market Share by Country (2020-2031)
Figure 28. Germany Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Molecular Oncology Market Share by Region (2020-2031)
Figure 36. China Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Molecular Oncology Market Share by Country (2020-2031)
Figure 44. Mexico Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Molecular Oncology Market Share by Country (2020-2031)
Figure 48. Turkey Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Molecular Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Roche Diagnostics Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 53. Illumina, Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 54. Qiagen N.V. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 55. Agilent Technologies, Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 57. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 58. Myriad Genetics, Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 59. Genomic Health, Inc. Revenue Growth Rate in Molecular Oncology Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies